Asthma in Adult Patients with COVID-19. Prevalence and Risk of Severe Disease.
Am J Respir Crit Care Med
; 203(7): 893-905, 2021 04 01.
Article
in English
| MEDLINE | ID: covidwho-1045637
ABSTRACT
Rationale Health outcomes of people with coronavirus disease (COVID-19) range from no symptoms to severe illness and death. Asthma, a common chronic lung disease, has been considered likely to increase the severity of COVID-19, although data addressing this hypothesis have been scarce until very recently.Objectives:
To review the epidemiologic literature related to asthma's potential role in COVID-19 severity.Methods:
Studies were identified through the PubMed (MEDLINE) and medRxiv (preprint) databases using the search terms "asthma," "SARS-CoV-2" (severe acute respiratory syndrome coronavirus 2), and "COVID-19," and by cross-referencing citations in identified studies that were available in print or online before December 22, 2020.Measurements and MainResults:
Asthma prevalence data were obtained from studies of people with COVID-19 and regional health statistics. We identified 150 studies worldwide that allowed us to compare the prevalence of asthma in patients with COVID-19 by region, disease severity, and mortality. The results of our analyses do not provide clear evidence of increased risk of COVID-19 diagnosis, hospitalization, severity, or mortality due to asthma.Conclusions:
These findings could provide some reassurance to people with asthma regarding its potential to increase their risk of severe morbidity from COVID-19.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Asthma
/
Severity of Illness Index
/
Global Health
/
COVID-19
/
Hospitalization
Type of study:
Observational study
/
Prognostic study
/
Randomized controlled trials
/
Reviews
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Am J Respir Crit Care Med
Journal subject:
Critical Care
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS